Invention Grant
- Patent Title: Thioindirubins
-
Application No.: US16643051Application Date: 2018-08-30
-
Publication No.: US11213510B2Publication Date: 2022-01-04
- Inventor: Sangkil Nam , David Horne , Ravi Salgia , Alexios Leandros Skaltsounis , Nicolas Gaboriaud-Kolar , Panagiotis Gerolymatos , Nikolaos Lougiakis
- Applicant: City of Hope , National and Kapodistrian University of Athens
- Applicant Address: US CA Duarte; GR Athens
- Assignee: City of Hope,National and Kapodistrian University of Athens
- Current Assignee: City of Hope,National and Kapodistrian University of Athens
- Current Assignee Address: US CA Duarte; GR Athens
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Agent Kenneth E. Jenkins; Joohee Lee
- International Application: PCT/US2018/048799 WO 20180830
- International Announcement: WO2019/046551 WO 20190307
- Main IPC: A61K31/4025
- IPC: A61K31/4025 ; A61P35/00 ; A61K31/496 ; A61K31/5377 ; A61K45/06 ; C07D409/04 ; C07D409/14 ; C07D413/14
Abstract:
Disclosed herein inter alia are compositions and methods for treating cancer using thioindirubin derivatives.
Public/Granted literature
- US20200345693A1 THIOINDIRUBINS Public/Granted day:2020-11-05
Information query
IPC分类:
